Lantheus Holdings IncNASDAQ:LNTH
- LAST PRICE79.9700
- TODAY'S CHANGE (%)-0.4800 (-0.5966%)
- Bid / Lots79.8800/ 2
- Ask / Lots80.0000/ 4
- Open / Previous Close79.7700 / 80.4500
- Day Range
- 52 Week Range
- Volume83,025
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LNTH |
|---|---|---|
| 09:32 ET | 6450 | 79.705 |
| 09:34 ET | 100 | 79.75 |
| 09:36 ET | 300 | 79.78 |
| 09:38 ET | 1200 | 79.915 |
| 09:39 ET | 600 | 80.32 |
| 09:41 ET | 800 | 80.22 |
| 09:43 ET | 200 | 80.23 |
| 09:45 ET | 1990 | 80.06 |
| 09:48 ET | 900 | 79.79 |
| 09:50 ET | 1450 | 79.72 |
| 09:52 ET | 2196 | 80.01 |
| 09:54 ET | 100 | 79.93 |
| 09:56 ET | 250 | 79.885 |
| 09:57 ET | 1628 | 80.095 |
| 09:59 ET | 200 | 80.23 |
| 10:01 ET | 400 | 79.92 |
| 10:03 ET | 1800 | 79.94 |
| 10:06 ET | 682 | 80.13 |
| 10:08 ET | 2168 | 79.87 |
| 10:10 ET | 1022 | 79.85 |
| 10:12 ET | 250 | 79.82 |
| 10:14 ET | 5873 | 79.91 |
| 10:15 ET | 914 | 80.04 |
| 10:17 ET | 729 | 80.23 |
| 10:19 ET | 625 | 80.4 |
| 10:21 ET | 200 | 80.28 |
| 10:24 ET | 200 | 80.21 |
| 10:26 ET | 100 | 80.13 |
| 10:28 ET | 825 | 80.2645 |
| 10:32 ET | 308 | 80.415 |
| 10:33 ET | 400 | 80.13 |
| 10:35 ET | 245 | 80.105 |
| 10:37 ET | 101 | 80.105 |
| 10:39 ET | 1300 | 80.3 |
| 10:42 ET | 700 | 80.295 |
| 10:44 ET | 600 | 80.16 |
| 10:46 ET | 1513 | 80.175 |
| 10:48 ET | 120 | 80.1783 |
| 10:50 ET | 260 | 80.03 |
| 10:51 ET | 1400 | 80.21 |
| 10:53 ET | 100 | 80.155 |
| 10:55 ET | 100 | 80.1 |
| 10:57 ET | 700 | 80.06 |
| 11:00 ET | 100 | 80.02 |
| 11:02 ET | 200 | 79.89 |
| 11:06 ET | 600 | 80.01 |
| 11:08 ET | 200 | 80.09 |
| 11:09 ET | 500 | 80 |
| 11:11 ET | 300 | 79.92 |
| 11:13 ET | 400 | 79.9 |
| 11:15 ET | 314 | 79.845 |
| 11:20 ET | 1087 | 79.98 |
| 11:22 ET | 200 | 79.98 |
| 11:26 ET | 200 | 79.995 |
| 11:27 ET | 570 | 80.05 |
| 11:29 ET | 1100 | 79.84 |
| 11:31 ET | 600 | 79.81 |
| 11:33 ET | 500 | 79.8713 |
| 11:36 ET | 200 | 79.84 |
| 11:38 ET | 200 | 79.8 |
| 11:40 ET | 800 | 79.835 |
| 11:42 ET | 932 | 79.96 |
| 11:44 ET | 1350 | 80 |
| 11:47 ET | 100 | 79.97 |
Jun 5, 2024
DJ S&P 500 Futures Rise In Premarket Trading; Hewlett Packard Ent, CrowdStrike Holdings Lead, from 7:30AM ET on Wednesday Jun 05, 2024 by Dow Jones
7:30AM ET on Wednesday Jun 05, 2024 by Dow Jones
Jun 3, 2024
Lantheus' AI-Enabled aPROMISE Now Available on Siemens Healthineers' syngo.via platform, from 8:30AM ET on Monday Jun 03, 2024 by Dow Jones
8:30AM ET on Monday Jun 03, 2024 by Dow Jones
May 28, 2024
Lantheus to Present at the William Blair 44th Annual Growth Stock Conference, from 8:00AM ET on Tuesday May 28, 2024 by Dow Jones
8:00AM ET on Tuesday May 28, 2024 by Dow Jones
May 15, 2024
DJ Lantheus Holdings Names Jeffrey Humphrey to Be Medical Chief, from 5:17PM ET on Wednesday May 15, 2024 by Dow Jones
5:17PM ET on Wednesday May 15, 2024 by Dow JonesLantheus Announces Executive Appointments to Accelerate Innovation, from 4:30PM ET on Wednesday May 15, 2024 by Dow Jones
4:30PM ET on Wednesday May 15, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Lantheus Holdings Inc | 5.6B | 12.2x | +35.30% |
Stevanato Group SpA | 5.5B | 33.1x | --- |
Merit Medical Systems Inc | 4.8B | 47.6x | +14.05% |
Glaukos Corp | 5.7B | -39.4x | --- |
Inspire Medical Systems Inc | 4.9B | -312.5x | --- |
Haemonetics Corp | 4.2B | 36.8x | +17.09% |
Company Information
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company. The Company is engaged in delivering science to enable clinicians to find, fight and follow disease to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Its Radiopharmaceutical Oncology diagnostics and therapeutic candidates help healthcare professionals (HCPs) find, fight, and follow cancer, with a focus in prostate cancer. Its Precision Diagnostic products assist HCPs to find and follow diseases, with a focus in cardiology. Its Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma solutions platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, NEUROLITE, Xenon-133, CARDIOLITE, RELISTOR, Automated Bone Scan Index, and others. Its commercial products are used by cardiologists, internal medicine physicians, and others.
Contact Information
- Headquarters
- 331 Treble Cove RdNORTH BILLERICA, MA, United States 01862
- Phone
- 978-671-8001
- Fax
- 302-636-5454
Executives
- Chairman of the Board
- Mary Heino
- President
- Paul Blanchfield
- Executive Chairman of the Board
- Brian Markison
- Chief Financial Officer, Treasurer
- Robert Marshall
- Chief Administrative Officer, General Counsel, Corporate Secretary
- Daniel Niedzwiecki
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.6B |
|---|---|
Revenue (TTM) | $1.4B |
Shares Outstanding | 69.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.52 |
EPS | $6.55 |
Book Value | $11.91 |
P/E Ratio | 12.2x |
Price/Sales (TTM) | 4.1 |
Price/Cash Flow (TTM) | 10.8x |
Operating Margin | 35.19% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
